[{"Assets_0_Q3_USD":"11842600000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.16","CommonStockDividendsPerShareDeclared_3_Q3_USD":"0.48","CommonStockSharesConverted_0_Q3_shares":"140800000.0","CommonStockSharesOutstanding_0_Q3_shares":"140800000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"0.31","EarningsPerShareBasic_3_Q3_USD":"0.33","EarningsPerShareDiluted_1_Q3_USD":"0.31","EarningsPerShareDiluted_3_Q3_USD":"0.32","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","MinorityInterest_0_Q3_USD":"100000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"482000000.0","NetIncomeLoss_1_Q3_USD":"44500000.0","NetIncomeLoss_3_Q3_USD":"46400000.0","OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_Q3_USD":"1231300000.0","RevenuesConverted_3_Q3_USD":"3663100000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":"6041800000.0","StockholdersEquity_0_Q3_USD":"6041700000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"141700000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"142800000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"141300000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"142500000.0","filed":"20171109","footnote":null,"form":"10-Q","fp":"Q3","fy":"2017.0","name":"PERRIGO CO PLC","period":"20170930","qtrs":"0","uom":"USD"}]